Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Case report

Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report

Authors: Naoki Kubo, Junichi Yoshizawa, Takaomi Hanaoka

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Mediastinal lymph node metastases occasionally occur in patients of advanced gastric cancer of the cardia with esophageal invasion, but they rarely occur in patients with gastric cancer of other sites. This report describes a case of a solitary metastasis to t a superior mediastinal lymph node after distal gastrectomy for gastric cancer of the antrum.

Case presentation

A 70-year-old man underwent curative distal gastrectomy for advanced gastric cancer of the antrum (pT2pN2M0, stage IIB). Postoperatively, he underwent adjuvant chemotherapy with S-1 (100 mg/day). Although the serum levels of his tumor markers increased after surgery, computed tomography scans did not detect evidence of early recurrence in the superior mediastinum. However, a 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) scan showed accumulation of fluorodeoxyglucose in the upper mediastinum with no evidence of recurrence elsewhere. Therefore, a solitary superior mediastinal lymph node was suspected to have a metastatic lesion derived from the gastric cancer. The patient underwent tumor resection right mini-thoracotomy two years and three months following gastrectomy. A pathological examination demonstrated moderately differentiated adenocarcinoma, confirming that it was a metastatic adenocarcinoma from the gastric cancer. The patient developed recurrences in the superior mediastinum and several right costa six months following the second surgery. He was treated with chemotherapy, but he died 18 months after the second operation.

Conclusion

We present a rare case of a solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer. An FDG-PET scan is useful for the diagnosis of mediastinal lymph node metastasis in gastric cancer. Metastasis to the superior mediastinal lymph nodes from gastric cancer in sites other than the cardia suggests systemic expansion of gastric cancer, and therefore, even a solitary metastasis may be related to a poor prognosis.
Literature
1.
go back to reference Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lym ph node involvement in advanced gastroesophageal gunction adenocarcinoma. J Thorac Cardiocasc Surg. 2007;134:378–85.CrossRef Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lym ph node involvement in advanced gastroesophageal gunction adenocarcinoma. J Thorac Cardiocasc Surg. 2007;134:378–85.CrossRef
2.
go back to reference Nunobe S, Ohyama S, Sonoo H, Hiki N, Fukunaga T, Seto Y, et al. Benefit of mediastinal and Para-aortic lymph-node dissection for advanced gastric cancer with esophageal invasion. J Surg Oncol. 2008;97:392–5.CrossRefPubMed Nunobe S, Ohyama S, Sonoo H, Hiki N, Fukunaga T, Seto Y, et al. Benefit of mediastinal and Para-aortic lymph-node dissection for advanced gastric cancer with esophageal invasion. J Surg Oncol. 2008;97:392–5.CrossRefPubMed
3.
go back to reference Siewert JR, Stein HJ, Feith M. Adenocatcinoma of the esophago-gastric junction. Scand J Surg. 2006;95:260–9.CrossRefPubMed Siewert JR, Stein HJ, Feith M. Adenocatcinoma of the esophago-gastric junction. Scand J Surg. 2006;95:260–9.CrossRefPubMed
4.
go back to reference Leers JM, DeMeester SR, Chan N, Ayazi S, Oezcilk A, Abate E, et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. Thorac Cardiovasc Surg. 2009;138:594–602.CrossRef Leers JM, DeMeester SR, Chan N, Ayazi S, Oezcilk A, Abate E, et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. Thorac Cardiovasc Surg. 2009;138:594–602.CrossRef
5.
go back to reference Inada T, Suda K, Igarashi S, Ogata Y. A case of advanced gastric cancer with mediastinal lymph node metastasis effectively treated with combined chemotherapy and surgery. Jpn J Cancer Clin. 1997;43:1565–8. Inada T, Suda K, Igarashi S, Ogata Y. A case of advanced gastric cancer with mediastinal lymph node metastasis effectively treated with combined chemotherapy and surgery. Jpn J Cancer Clin. 1997;43:1565–8.
6.
go back to reference Tanaka T, Fujino T, Sugiura T, Makita K. A recurrent gastric cancer patient with multiple organ metastasis who achieved partial remission by multidisciplinary therapy (radiochemotherapy plus hyperthermia). Gan To Kagaku Ryoho. 2009;36:859–61. Tanaka T, Fujino T, Sugiura T, Makita K. A recurrent gastric cancer patient with multiple organ metastasis who achieved partial remission by multidisciplinary therapy (radiochemotherapy plus hyperthermia). Gan To Kagaku Ryoho. 2009;36:859–61.
7.
go back to reference Libson E, Bloom RA, Halperin I. Mediastinal lymph node metastases from gastrointestinal carcinoma. Cancer. 1987;59:1490–3.CrossRefPubMed Libson E, Bloom RA, Halperin I. Mediastinal lymph node metastases from gastrointestinal carcinoma. Cancer. 1987;59:1490–3.CrossRefPubMed
8.
go back to reference Baltax HA, Constable WC. Mediastinal lymph node visualization in the absence of intra thoracic disease. Radiology. 1968;90:94–8.CrossRef Baltax HA, Constable WC. Mediastinal lymph node visualization in the absence of intra thoracic disease. Radiology. 1968;90:94–8.CrossRef
9.
go back to reference Rino Y, Imada T, Takanashi Y, Kobayashi O, Sairenji M, Motohashi H. Route from the paraaortic lymphatic system to the tracheobronchial lymph nodes evidenced on lymphangiogram in a patient with gastric cancer. Gastric Cancer. 2004;7:176–7.CrossRefPubMed Rino Y, Imada T, Takanashi Y, Kobayashi O, Sairenji M, Motohashi H. Route from the paraaortic lymphatic system to the tracheobronchial lymph nodes evidenced on lymphangiogram in a patient with gastric cancer. Gastric Cancer. 2004;7:176–7.CrossRefPubMed
10.
go back to reference McLoud TC, Kalisher L, Stark P, Greene R. Intrathoracic lymph node metastases from extrathoracic neoplasms. AJR Am Roentgenol. 1978;131:403–7.CrossRef McLoud TC, Kalisher L, Stark P, Greene R. Intrathoracic lymph node metastases from extrathoracic neoplasms. AJR Am Roentgenol. 1978;131:403–7.CrossRef
11.
go back to reference Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic or recurrent gastric cancer. J Nucl Med. 2003;44:690–9.PubMed Yoshioka T, Yamaguchi K, Kubota K, Saginoya T, Yamazaki T, Ido T, et al. Evaluation of 18F-FDG PET in patients with advanced, metastatic or recurrent gastric cancer. J Nucl Med. 2003;44:690–9.PubMed
12.
go back to reference Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58(3):215–21.CrossRefPubMed Jadvar H, Tatlidil R, Garcia AA, Conti PS. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003;58(3):215–21.CrossRefPubMed
13.
go back to reference Shiroma H, Isa T, Teruya T, Gakiya A, Nakauchi A, Higa J. A case of gastric cancer with middle mediastinum lymph node metastasis in which FDG-PET was useful for diagnosis. J Jpn Surg Assoc. 2007;68:2223–8.CrossRef Shiroma H, Isa T, Teruya T, Gakiya A, Nakauchi A, Higa J. A case of gastric cancer with middle mediastinum lymph node metastasis in which FDG-PET was useful for diagnosis. J Jpn Surg Assoc. 2007;68:2223–8.CrossRef
14.
go back to reference Matsunaga T, Saito H, Miyatani K, Takaya S, Fukumoto Y, Osaki T, et al. Gastric adenocarcinoma with thymic metastasis after curative resection: a case report. J Gastric Cancer. 2014;14:2017–0.CrossRef Matsunaga T, Saito H, Miyatani K, Takaya S, Fukumoto Y, Osaki T, et al. Gastric adenocarcinoma with thymic metastasis after curative resection: a case report. J Gastric Cancer. 2014;14:2017–0.CrossRef
15.
go back to reference Nakamura M, Iwahashi M, Nakamori M, Naka T, Ojima T, Katsuda M, et al. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinoma in the gastroesophageal junction. Am Surg. 2012;78:567–73. Nakamura M, Iwahashi M, Nakamori M, Naka T, Ojima T, Katsuda M, et al. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinoma in the gastroesophageal junction. Am Surg. 2012;78:567–73.
16.
go back to reference Kobayashi O, Sugiyama Y, Konishi K, Kanari M, Cho H, Tsuburaya A, et al. Solitary metastasis to the left axillary lymph node after curative gastrectomy in gastric cancer. Gastric Cancer. 2002;5:173–6.CrossRefPubMed Kobayashi O, Sugiyama Y, Konishi K, Kanari M, Cho H, Tsuburaya A, et al. Solitary metastasis to the left axillary lymph node after curative gastrectomy in gastric cancer. Gastric Cancer. 2002;5:173–6.CrossRefPubMed
17.
go back to reference Nashimoto A, Sasaki JSM, Tanaka O, Tsutsui M, Tsuchiya Y, et al. Disease-free survival for 6 years and 4 months after dissection of recurrent abdominal paraaortic nodes (no.16) in gastric cancer: report of a case. Surg Today. 1997;27:169–73.CrossRefPubMed Nashimoto A, Sasaki JSM, Tanaka O, Tsutsui M, Tsuchiya Y, et al. Disease-free survival for 6 years and 4 months after dissection of recurrent abdominal paraaortic nodes (no.16) in gastric cancer: report of a case. Surg Today. 1997;27:169–73.CrossRefPubMed
Metadata
Title
Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report
Authors
Naoki Kubo
Junichi Yoshizawa
Takaomi Hanaoka
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4555-7

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine